These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2106393)

  • 1. Tissue-type plasminogen activator: intracoronary applications.
    Tiefenbrunn AJ
    Cathet Cardiovasc Diagn; 1990 Feb; 19(2):108-15. PubMed ID: 2106393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with intracoronary tissue plasminogen activator: results of a multicenter registry. Intracoronary t-PA Registry Investigators.
    Cathet Cardiovasc Diagn; 1995 Mar; 34(3):196-201. PubMed ID: 7497484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-type plasminogen activator therapy versus primary coronary angioplasty: impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction.
    Agati L; Voci P; Hickle P; Vizza DC; Autore C; Fedele F; Feinstein SB; Dagianti A
    J Am Coll Cardiol; 1998 Feb; 31(2):338-43. PubMed ID: 9462577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic thrombolysis for early intracoronary stent thrombosis.
    Fruhwald FM; Luha O; Eber B; Schumacher M; Zweiker R; Klein W
    Lancet; 1995 Jul; 346(8967):119-20. PubMed ID: 7603192
    [No Abstract]   [Full Text] [Related]  

  • 5. Experience with low-dose intracoronary recombinant tissue-type plasminogen activator for nonacute total occlusions before percutaneous transluminal coronary angioplasty.
    Ruocco NA; Currier JW; Jacobs AK; Ryan TJ; Faxon DP
    Am J Cardiol; 1991 Dec; 68(17):1609-13. PubMed ID: 1746461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant tissue plasminogen activator (rt-PA): is it the thrombolytic agent of choice for an evolving acute myocardial infarction?
    Sherry S
    Am J Cardiol; 1987 Apr; 59(9):984-9. PubMed ID: 3105303
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronary thrombolysis with recombinant tissue plasminogen activator. Intracoronary vs intravenous administration.
    Gu SA; Ducas J; Wolfe K; Patton JN; Prewitt RM
    Chest; 1991 Jul; 100(1):201-6. PubMed ID: 1905615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary tenecteplase in STEMI with massive thrombus.
    Jayagopal PB; Sarjun Basha KM
    Indian Heart J; 2018; 70(3):446-449. PubMed ID: 29961467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012
    [No Abstract]   [Full Text] [Related]  

  • 10. Retrograde coronary venous administration of recombinant tissue-type plasminogen activator: a unique and effective approach to coronary artery thrombolysis.
    Miyazaki A; Tadokoro H; Drury JK; Rydén L; Haendchen RV; Corday E
    J Am Coll Cardiol; 1991 Aug; 18(2):613-20. PubMed ID: 1906906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary recombinant tissue-type plasminogen activator (rt-PA).
    Tiefenbrunn AJ
    Coron Artery Dis; 1996 Sep; 7(9):637-40. PubMed ID: 8950493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of tissue plasminogen activator in the coronary care unit for acute closure after coronary angioplasty.
    Alzarka A; Haft JI; Goldstein JE
    Chest; 1990 May; 97(5):1241-2. PubMed ID: 2110053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coronary thrombolysis with urokinase and t-PA--comparison of intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):782-9. PubMed ID: 12436616
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined revascularization strategy for acute myocardial infarction in patients with intracoronary thrombus: preceding intracoronary thrombolysis and subsequent mechanical angioplasty.
    Ishibashi F; Saito T; Hokimoto S; Noda K; Moriyama Y; Oshima S
    Jpn Circ J; 2001 Apr; 65(4):251-6. PubMed ID: 11316117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of adjunctive intracoronary thrombolytic therapy during complex percutaneous coronary intervention: initial experience with intracoronary tenecteplase.
    Kelly RV; Crouch E; Krumnacher H; Cohen MG; Stouffer GA
    Catheter Cardiovasc Interv; 2005 Nov; 66(3):327-32. PubMed ID: 16208711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator.
    Prewitt RM; Gu S; Garber PJ; Ducas J
    J Am Coll Cardiol; 1992 Dec; 20(7):1626-33. PubMed ID: 1452937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful revascularization of coronary artery occluded by massive intracoronary thrombi with alteplase and percutaneous coronary intervention.
    Kim JS; Kim JH; Jang HH; Lee YW; Song SG; Park JH; Chun KJ
    J Atheroscler Thromb; 2010 Jul; 17(7):768-70. PubMed ID: 20467185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin requirement in tissue-type plasminogen activator-induced experimental coronary thrombolysis: comparison with urokinase-induced coronary thrombolysis.
    Susawa T; Yui Y; Hattori R; Takahashi M; Aoyama T; Takatsu Y; Sakaguchi K; Yui N; Kawai C
    Jpn Circ J; 1987 Apr; 51(4):431-5. PubMed ID: 2441082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary thrombolysis. Comparative effects of intracoronary administration of recombinant tissue plasminogen activator and urokinase.
    Gu S; Ducas J; Patton JN; Greenberg D; Prewitt RM
    Chest; 1992 Jun; 101(6):1684-90. PubMed ID: 1600792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rate of administration of recombinant tissue plasminogen activator on efficacy of coronary thrombolysis.
    Prewitt RM; Gu S; Schick U; Ducas J
    Angiology; 1994 Aug; 45(8):687-94. PubMed ID: 8048778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.